Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Эли Лилли Энд КомпаниfiledCriticalЭли Лилли Энд Компани
Priority claimed from PCT/US2019/042604external-prioritypatent/WO2020023312A1/en
Publication of EA202092895A1publicationCriticalpatent/EA202092895A1/en
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents
(AREA)
Abstract
Данное изобретение относится к агонистическим антителам против CD226 человека, которые могут быть полезны для лечения солидных раковых опухолей.This invention relates to agonist antibodies against human CD226, which may be useful for the treatment of solid cancers.
EA202092895A2019-01-232019-07-19
AGONISTIC ANTIBODIES AGAINST CD226
EA202092895A1
(en)